Abstract
BACKGROUND The combination of ivosidenib - an inhibitor of mutant isocitrate dehydrogenase 1 (IDH1) - and azacitidine showed encouraging clinical acti......
小提示:本篇文献需要登录阅读全文,点击跳转登录